Dr. Shafi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-9295
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1995 - 1997
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1991 - 1995
- Aga Khan Medical CollegeClass of 1989
- F.G. College for WomenBachelors, Pre-Medical Science, 1982
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2003 - 2025
- OK State Medical License 2020 - 2021
- VA State Medical License 1994 - 2004
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Investigator Initiated Research Award 2014
- Awarded Top 10 abstract OESO The Esophagus 12th World Conference 2013
- Fellow (AGAF) American Gastroenterological Association, 2011
- Join now to see all
Clinical Trials
- Domperidone in Treating Patients With Gastrointestinal Disorders Start of enrollment: 2012 Oct 23
- Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants Start of enrollment: 2017 Jan 24
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- The Effect of Immune Checkpoint Inhibitor Therapy on Pre-Existing Gastroparesis and New Onset of Symptoms of Delayed Gastric Emptying.Andres C Urias Rivera, Antonio Pizuorno Machado, Malek Shatila, George Triadafilopoulos, Jennifer L McQuade
Cancers. 2024-07-26 - Gastrointestinal toxicities of proteasome inhibitor therapy.Jay Shah, Samanthika Devalaraju, Elliot Baerman, Irene Jeong-Ah Lee, Kei Takigawa
Journal of Cancer Research and Clinical Oncology. 2024-07-05 - 3 citationsPneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.Gabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, Yang Lu, Mehmet Altan
Journal of Cancer Research and Clinical Oncology. 2023-12-01
Journal Articles
- Continuing Medical Education Questions: November 2018Mehnaz Shafi, MD, Nature
- Role of Argon Plasma Coagulation in Management of Bleeding GI Tumors: Evaluating Outcomes and SurvivalThosani N, Batra S, Ghouri Y, Raju G, Shafi MA, Guha S, The Turkish Journal Gastroenterology, 8/1/2014
- Do Females Patients prefer Female Enodoscopists?Shafi MA, AGA Perspectives, 5/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Decision-making software for probe-confocal laser endomicroscopy (PCLE) in Barrett's esophagus: A pilot study.Coron E, Ahmed A, Al-Kawas F, Brugge WR, Caillol F, Carr-Locke DL, Etienne J, Gaddam S, Gan SI, Guaraldi da Silva S, Haluszka O, Iyer P, Joshi V, Kaul V, Kothari S, Li..., UEG Week, 10/1/2014
- Effect of prokinetic medications one year after gastric electrical stimulation in patients with refractory gastroparesis. Poster PresentationHameed A, Stroehlein JR, Shafi MA, DoIM Research, 5/1/2014
- Adenoma detection rate (ADR) and serrated adenoma detection rate (Sdr) during screening colonoscopy with and without a personal cancer history (Pch) in a tertiary refe...Weston B, Ross WA, Lum P, Thirumurthi S, Miller E, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Rashid A, Shafi MA,..., DDW, 5/1/2014
- Join now to see all
Lectures
- Gastroparesis and the role of Gastric Electrical Stimulaton5/1/2014
- Decision-making software for probe-confocal laser endomicroscopy (PCLE) in Barrett's esophagus: A pilot study.Opio en Provence, France - 4/1/2014
- Endoscopic Management of Early Esophageal Cancer and Barrett's Esophagus with Dysplasia.10/4/2013
- Join now to see all
Other
- Continuing Medical Education Questions: May 2018Mehnaz Shafi, MD, Nature
https://www.doximity.com/articles/cae8fcc4-d6d0-4d4a-a0d1-0a377627fe5e
UpToDate, Wolters Kluwer Health - 2012-10-15
Authored Content
- Tu1148 ENDOSCOPIC MUCOSAL RESECTION AND RADIOFREQUENCY ABLATION ARE SAFE AND EFFECTIVE IN CURATIVE TREATMENT OF EARLY ESOPHAGEAL ADENOCARCINOMAMay 2018
- Tu1199 COMPARISON OF THE SUCCESS OF ENDOSCOPIC TREATMENT IN EARLY ESOPHAGEAL SQUAMOUS CELL CANCER AND ESOPHAGEAL ADENOCARCINOMA. A NINE YEARS EXPERIENCE FROM A CANCER HOSPITALMay 2018
- Tu1199 COMPARISON OF THE SUCCESS OF ENDOSCOPIC TREATMENT IN EARLY ESOPHAGEAL SQUAMOUS CELL CANCER AND ESOPHAGEAL ADENOCARCINOMA. A NINE YEARS EXPERIENCE FROM A CANCER HOSPITALMay 2018
- Tu1148 ENDOSCOPIC MUCOSAL RESECTION AND RADIOFREQUENCY ABLATION ARE SAFE AND EFFECTIVE IN CURATIVE TREATMENT OF EARLY ESOPHAGEAL ADENOCARCINOMAMay 2018
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: